Secondary Hyperparathyroidism in Response to Hypocalcemia (High Parathyroid Hormone)
Vitamin D Deficiency/Resistance
Etiology
Nutritional Vitamin D Deficiency and Decreased Cutaneous Vitamin D Synthesis
Vitamin D Deficiency Due to Abnormal Synthesis and Catabolism
Chronic Kidney Disease (CKD): low calcitriol (1,25 dihydroxyvitamin D) production due to decreased glomerular filtration rate, loss of the 1-alpha-hydroxylase enzyme secondary to structural renal disease, and suppression of enzyme activity due to hyperphosphatemia and resultant increased circulating FGF23 levels
Drugs (Inducers of P-450 enzyme, Which Metabolizes Calcidiol to Inactive Vitamin D Metabolites): phenytoin, phenobarbital, carbamazepine, oxcarbazepine, isoniazid, theophylline, rifampin
Acute hyperphosphatemia, resulting from increased phosphate intake (phosphate enemas, oral phosphate replacement) in the setting of renal failure, can result in acute hypocalcemia
Chronic hyperphosphatemia is usually due to decreased phosphate clearance in chronic kidney disease; in these cases, primary impairment of calcitriol synthesis (resulting in decreased intestinal calcium absorption) further excaerbates the hypocalcemia
Physiology: hyperphosphatemia results in calcium deposition, mostly in bone (but also in extraskeletal tissues)
Osteoblastic Bone Metastases
Etiology
Breast Cancer (see Breast Cancer, [[Breast Cancer]])
Physiology: due to deposition of calcium in the newly formed bone around the tumor
Rhabdomyolysis (see Rhabdomyolysis, [[Rhabdomyolysis]]): patients are typically hypocalcemic during the oliguric phase of acute kidney injury (due to acute tubular necrosis)
Physiology: in setting of decreased renal excretion of phosphate, hyperphosphatemia from tissue breakdown results in calcium deposition, mostly in bone (but also in extraskeletal tissues)
Physiology: in setting of decreased renal excretion of phosphate, hyperphosphatemia from tumor breakdown results in calcium deposition, mostly in bone (but also in extraskeletal tissues)
Epidemiology: more frequently seen when potent bisphosphonates (such as zoledronate) are used and in patients with underlying vitamin D deficiency, unrecognized hypoparathyroidism, or chronic kidney disease
Denosumab (Xgeva, Prolia) (see Denosumab, [[Denosumab]])
Pharmacology: fully human monoclonal antibody to the receptor activator of nuclear factor kappaB ligand (RANKL), which is an osteoclast differentiating factor
Other Drugs/Toxins
5-Fluorouracil and Leucovorin (see 5-Fluorouracil, [[5-Fluorouracil]])
Epidemiology: hypocalcemia occured in 65% of cases (in one series)
Physiology: probably by decreasing calcitriol production
Trousseau Sign (see Trousseau Sign, [[Trousseau Sign]]): inflated blood pressure cuff for 3 min will elicit carpopedal spasm in hand/forearm
Other Name for Sign: “main d’accoucheur” (French for “hand of the obstetrician”) because it resembles the position of an obstetrician’s hand in delivering a baby
Macrocytic Anemia (see Anemia, [[Anemia]]): with abnormal Schilling test
Treatment
Oral Calcium Replacement
Agents
Calcium Carbonate (Oscal, Tums) (see Calcium Carbonate, [[Calcium Carbonate]])
Intravenous Calcium Replacement
Clinical Efficacy
Systematic Review of Parenteral Calcium Replacement in Critical Care Patients (Cochrane Database Syst Rev, 2008) [MEDLINE]: no evidence that parenteral calcium replacement improves outcome in critically ill patients
Agents
Calcium Chloride (in 10 ml = 10%) (see Calcium Chloride, [[Calcium Chloride]]): 1 amp over 30-60 min
Calcium Gluconate (see Calcium Gluconate, [[Calcium Gluconate]]): 1 amp IV over 30-60 min
Avoid Use in Liver Disease
Adverse Effects
Carpopedal Spasm: with rapid infusion
References
Massive blood replacement: correlation of ionized calcium, citrate, and hydrogen ion concentration. Anesth Analg 1979; 58:274-278 [MEDLINE]
Ionized hypocalcemia during sepsis. Crit Care Med 2000; 28:266-268 [MEDLINE]
Electrolyte disturbances in the intensive care unit. Semin Dial 2006; 19:496-501 [MEDLINE]
Parenteral calcium for intensive care unit patients. Cochrane Database Syst Rev 2008 Oct 8; (4):CD006163. DOI: 1002/14651858.CD006163.pub2 [MEDLINE]
Calcium homeostasis during magnesium treatment in aneurysmal subarachnoid hemorrhage. Neurocrit Care 2008;8(3):413 [MEDLINE]